Company intelligence / Profile preview

eMolecules

San Diego, California, USAemolecules.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

eMolecules operates the industry’s largest digital marketplace for chemical building blocks, screening compounds, and bioreagents. It enables rapid procurement of over 100 million in-stock SKUs from hundreds of suppliers worldwide. The company has expanded its offering through acquisitions to include compound management services and automated synthesis solutions. It serves pharmaceutical, biotech, CROs, academia, and agrochemical sectors globally.

Modalities: Small moleculeBiologic
Industry: Chemicals & Materials

Partnerships

Partnerships with hundreds of specialty chemical suppliers globally (>150 suppliers), integration with leading drug discovery companies’ procurement platforms.

Beyond the preview

Go deeper on eMolecules.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on eMolecules.

Explore the full profile